 "Pfizer Covid-19 jab produces less antibodies against Delta variant: Lancet")
People fully vaccinated with the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant first identified in India compared to the original strain, according to research published in The Lancet journal.
The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.
It supports current plans in the UK to reduce the dose gap between
The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.
It supports current plans in the UK to reduce the dose gap between
Disclaimer: No Business Standard Journalist was involved in creation of this content
